Annual Working Capital
-$37.52 M
-$23.13 M-160.73%
December 31, 2023
Summary
- As of February 8, 2025, NKGN annual working capital is -$37.52 million, with the most recent change of -$23.13 million (-160.73%) on December 31, 2023.
- During the last 3 years, NKGN annual working capital has risen by +$17.61 million (+31.94%).
- NKGN annual working capital is now -160.73% below its all-time high of -$14.39 million, reached on December 31, 2022.
Performance
NKGN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$50.16 M
-$14.28 M-39.81%
June 30, 2024
Summary
- As of February 8, 2025, NKGN quarterly working capital is -$50.16 million, with the most recent change of -$14.28 million (-39.81%) on June 30, 2024.
- Over the past year, NKGN quarterly working capital has dropped by -$21.66 million (-76.00%).
- NKGN quarterly working capital is now -248.54% below its all-time high of -$14.39 million, reached on December 31, 2022.
Performance
NKGN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NKGN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -160.7% | -76.0% |
| 3 y3 years | +31.9% | - |
| 5 y5 years | +31.9% | - |
NKGN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -160.7% | +31.9% | -248.5% | at low |
| 5 y | 5-year | -160.7% | +31.9% | -248.5% | at low |
| alltime | all time | -160.7% | +31.9% | -248.5% | at low |
NKGen Biotech Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$50.16 M(+39.8%) |
| Mar 2024 | - | -$35.88 M(-4.4%) |
| Dec 2023 | -$37.52 M | -$37.52 M(+31.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$28.50 M(+34.7%) |
| Jun 2023 | - | -$21.16 M(+47.0%) |
| Dec 2022 | -$14.39 M(-73.9%) | -$14.39 M |
| Dec 2021 | -$55.13 M | - |
FAQ
- What is NKGen Biotech annual working capital?
- What is the all time high annual working capital for NKGen Biotech?
- What is NKGen Biotech annual working capital year-on-year change?
- What is NKGen Biotech quarterly working capital?
- What is the all time high quarterly working capital for NKGen Biotech?
- What is NKGen Biotech quarterly working capital year-on-year change?
What is NKGen Biotech annual working capital?
The current annual working capital of NKGN is -$37.52 M
What is the all time high annual working capital for NKGen Biotech?
NKGen Biotech all-time high annual working capital is -$14.39 M
What is NKGen Biotech annual working capital year-on-year change?
Over the past year, NKGN annual working capital has changed by -$23.13 M (-160.73%)
What is NKGen Biotech quarterly working capital?
The current quarterly working capital of NKGN is -$50.16 M
What is the all time high quarterly working capital for NKGen Biotech?
NKGen Biotech all-time high quarterly working capital is -$14.39 M
What is NKGen Biotech quarterly working capital year-on-year change?
Over the past year, NKGN quarterly working capital has changed by -$21.66 M (-76.00%)